Zoetis Inc.

Zoetis Inc. is an animal health company headquartered in Parsippany, New Jersey. The company separated from Pfizer and went public in 2013. Its shares trade on the New York Stock Exchange under the ticker ZTS, and it is a member of the S&P 500 index. Its activities rest on developing medicines, vaccines and diagnostic products for animals.

Products fall into two main groups. The companion animal group includes products for dogs and cats; Apoquel and Cytopoint, used for allergic itch in dogs, and Librela and Solensia, used for pain caused by osteoarthritis, are examples. Parasite prevention products and vaccines are also part of it. The livestock group includes vaccines, infection treatments and nutritional support products used in raising cattle, pigs, poultry and fish. Diagnostic products and genetic tests are also part of the portfolio.

Those following Zoetis stock typically track trends in pet ownership and veterinary visits, the approval process for new products, developments in animal disease and the arrival of competing medicines on the market. On the ZTS page at Lzzo.com the price is shown in US dollars, and a price chart and technical indicators appear on the same page.